Seeking Alpha

Shares of Compugen (CGEN) are up more than 10% after the Israeli biotech company said it...

Shares of Compugen (CGEN) are up more than 10% after the Israeli biotech company said it discovered a new protein for the treatment of autoimmune disorders. The new protein (CGEN-15001) is the extracellular region of a new membrane protein, and could potentially be used to treat MS, rheumatoid arthritis, inflammatory bowel disease and type 1 diabetes.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|